Medical and Pharmaceutical Regulus Therapeutics shares jump 135% on news of acquisition by Novartis The buyer is offering a significant premium to acquire Regulus Joseph MortonApril 30, 2025
Medical and Pharmaceutical TG Therapeutics stock spikes on strong financials and optimism for its flagship drug The company's product for relapsing forms of multiple sclerosis (RMS), is its primary source of its most recent success Joseph MortonMarch 3, 2025
Medical and Pharmaceutical University of Waterloo and Princess Margaret Cancer Centre collaborate on innovative cancer research The Canadian Cancer Society reports that healthcare professionals diagnose over 100 types of cancer-related diseases each year Joseph MortonJanuary 21, 2025
Medical and Pharmaceutical New drug could open personalized treatment strategies for prostate cancer Screening men for BCL2 could allow for the development of personalized treatment plans Joseph MortonSeptember 17, 2024